FFAR2 and neoplasm: Furthermore, MDSCs deletion in vivo, co-injection of MDSCs with tumor cells and myeloid cell conditional knockout Ffar2 mouse tumor models showed that FFAR2 drive tumor progression mainly through MDSCs.